CG 201

Drug Profile

CG 201

Alternative Names: CG-201; CG201 - CG Therapeutics

Latest Information Update: 22 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CG Therapeutics
  • Class Antibodies; Cancer vaccines; Contraceptives; Gonadotropin-vaccines; Placental-hormone-vaccines; Pregnancy-protein-vaccines; Vaccines
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 22 Jun 2015 Discontinued - Phase-II for Solid tumours in USA (Parenteral)
  • 04 Apr 2005 Phase-II clinical trials in Solid tumours in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top